Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Global Medtech Guidance Tracker: December 2020

Executive Summary

Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Sixty-seven guidance documents have been posted on the tracker since its last update.

You may also be interested in...



EU Regulatory Roundup, December 2020: UK Break With EU Tops News Amidst MDR Preparations Latest

Four out of 10 of Medtech Insight's top EU stories were dominated by news related to the implications for medtech of the UK’s final break from the EU on 31 December. But no one should ignore the pressure that implementation of the new EU medtech regulations is causing.

The Times They Are A-Changin’: Opportunities In Medtech Regulation For The UK After Brexit

The end of a calendar year is a chance to reflect on times past and the future, to make resolutions and look ahead to changes for the better. With Brexit in mind, the turn of 2020 is a time to prophesize on UK medtech’s immediate future.

Global Regulators Issue Advice On Clinical Comparability Of Biosimilar MAbs

The International Pharmaceutical Regulators Programme has documented various approaches currently being used for the clinical comparability of biosimilar monoclonal antibodies in different jurisdictions.

Topics

UsernamePublicRestriction

Register

RS150923

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel